Novartis, the Swiss pharmaceutical giant, has warned that its investments in Britain are at risk because animal rights campaigners are threatening the safety of its scientists.
Daniel Vasella, chairman of the group, said that the company would increasingly be focusing its research funds outside Europe, where growth is likely to be flat in the years ahead.
He was speaking in China after the signing of a pact with a Shanghai medical institution to identify the active ingredients in herbs and fungi used in traditional Chinese medicine.
http://www.taipeitimes.com/News/worldbiz/archives/2004/11/16/2003211328
Printer-friendly format
Email this thread to a friend
Bookmark this thread
(1000+ posts)
Send PM |
Profile |
Ignore